Drug Development Communication Plan
This is a practical guide to building a communication plan for a drug development project — who gets what information, when, how and from whom, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Communication Plan is
A communication plan is who gets what information, when, how and from whom. For the full concept and how it works in general, see Communication Plan. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built communication plan gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Audiences
- Messages / information needs
- Frequency and channel
- Owner
Drug Development-specific considerations
Tailor the communication plan to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the communication plan would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.